4//SEC Filing
683 Capital Partners, LP 4
Accession 0001140361-18-006601
CIK 0001130598other
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 4:37 PM ET
Size
8.1 KB
Accession
0001140361-18-006601
Insider Transaction Report
Form 4
683 Capital Partners, LP
10% Owner
Transactions
- Purchase
Common Stock, $0.01 par value
2018-02-08$1.04/sh+200,000$207,120→ 2,664,934 total(indirect: By 683 Capital Partners, LP)
683 Capital Management, LLC
10% Owner
Transactions
- Purchase
Common Stock, $0.01 par value
2018-02-08$1.04/sh+200,000$207,120→ 2,664,934 total(indirect: By 683 Capital Partners, LP)
Footnotes (2)
- [F1]This Form 4 is filed jointly by 683 Capital Management, LLC ("683 Management"), 683 Capital Partners, LP ("683 Partners") and Ari Zweiman (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
- [F2]Represents securities held directly by 683 Partners. 683 Management is the investment manager of 683 Partners. Ari Zweiman is the Managing Member of 683 Management. As a result, each of 683 Management and Ari Zweiman may be deemed to beneficially own the securities held by 683 Partners.
Documents
Issuer
Onconova Therapeutics, Inc.
CIK 0001130598
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001380126
Filing Metadata
- Form type
- 4
- Filed
- Feb 11, 7:00 PM ET
- Accepted
- Feb 12, 4:37 PM ET
- Size
- 8.1 KB